Therapeutics: Low-density lipoprotein receptor (LDLR)

Cancer

INDICATION: Pancreatic cancer

In vitro, mouse and patient sample studies suggest inhibiting LDLR could help

Read the full 149 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE